EarningsQ3 2024 Earnings Report

BridgeBio Pharma (2CL) Q3 2024 Earnings Report

3 Followers

DE:2CL Q3 2024 EPS Results

Actual EPS-€0.77

Consensus EPS-€0.90

Beat/MissBeat by +€0.13

One Year Ago EPS-€0.96

Actual Revenue€2.44M

Expected Revenue€1.49M

Beat/MissBeat by +€943.25K

YoY Revenue Growth-33.22%

QuarterQ3 2024

Date11/12/2024

TimeBefore Open

Conference CallTuesday, November 12, 2024

DE:2CL Upcoming Earnings

BridgeBio Pharma's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2026 (Q3)	-0.50 / -	-0.848	―
Aug 10, 2026	2026 (Q2)	-0.51 / -0.70	-0.848	17.89% (+0.15)
May 07, 2026	2026 (Q1)	-0.61 / -0.75	-0.785	4.55% (+0.04)
Feb 24, 2026	2025 (Q4)	-0.64 / -0.89	-1.249	28.57% (+0.36)
Oct 29, 2025	2025 (Q3)	-0.80 / -0.85	-0.767	-10.47% (-0.08)
Aug 05, 2025	2025 (Q2)	-0.71 / -0.85	-0.348	-143.59% (-0.50)
Apr 29, 2025	2025 (Q1)	-0.82 / -0.79	-0.178	-340.00% (-0.61)
Feb 20, 2025	2024 (Q4)	-1.00 / -1.25	-0.857	-45.83% (-0.39)
Nov 12, 2024	2024 (Q3)	-0.90 / -0.77	-0.964	20.37% (+0.20)
Aug 01, 2024	2024 (Q2)	-0.89 / -0.35	-0.875	60.20% (+0.53)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed